Abstract
Ovine coccidiosis caused by Eimeria spp. can negatively impact health and overall productive performance in sheep with mortalities up to 20% in lambs. It is characterized by high production of pro-inflammatory cytokines and oxidative stress that can damage intestinal tissue. Currently, only drugs are used for the treatment of ovine coccidiosis. Nevertheless, anticoccidial resistance and the concern of drug residues in edible tissues and milk have prompted the evaluation of alternatives to prevent and control this disease. Based on preliminary findings, the use of Curcuma longa dietary supplementation was evaluated in this trial. Twenty crossbred lambs naturally infected with Eimeria spp., aged 28-days-old with an average weight of 12kg, were divided in five groups. Three groups were treated orally for 14 days with 50mg/kg, 100mg/kg, or 200mg/kg of C. longa. A placebo-treated group and untreated controls were included in this trial, too. Stool samples were obtained every other day to determine anticoccidial efficacy. Also, animals were weighed on day 0 and 42. To evaluate the immunomodulatory activity of curcumin, a proinflammatory (IFN-γ) and an immunoregulatory (IL-10) cytokine were measured by ELISA. Lipid peroxidation and nitrite generation were determined by means of the serum malondialdehyde test and the Griess reaction, respectively. C. longa anticoccidial activity increased over time in treated groups and reached a 100% efficacy on day 42. Animals treated with 200mg/kg of this plant gained twice the daily weight recorded for untreated groups. IL-10 levels were higher in supplemented animals, whereas lipid peroxidation and generation of nitrites were significantly lower. Results showed that curcumin administration may reduce oocyst output, weight-loss, inflammation and oxidative stress-related effects caused by Eimeria spp. infection in lambs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.